Long Telomeres Bypass the Requirement for Telomere Maintenance in Human Tumorigenesis

Cell Reports

Volumn 1, Issue 2, 2012, Pages 91-98

  Taboski, Michael A S ^a,h   Sealey, David C F ^a,d   Dorrens, Jennifer ^b   Tayade, Chandrakant ^c,e   Betts, Dean H ^c,f   Harrington, Lea ^a,b,g  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF GUELPH   (Canada)

^d Janssen Inc   (Canada)

^e QUEEN S UNIVERSITY   (Canada)

^f UNIVERSITY OF WESTERN ONTARIO   (Canada)

^g UNIVERSITÉ DE MONTRÉAL   (Canada)

^h DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DNA FLANKING REGION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; GENE CONTROL; GENETIC SUSCEPTIBILITY; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; LOXP SITE; MOUSE; NONHUMAN; ONCOGENE RAS; SIGNAL TRANSDUCTION; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING;

ANIMALS; BIOCATALYSIS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MICE; MUTATION; TELOMERASE; TELOMERE; TELOMERE HOMEOSTASIS;

MUS;

EID: 84861150055     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2011.12.004     Document Type: Article

References (53)

1. Allsopp R.C., Vaziri H., Patterson C., Goldstein S., Younglai E.V., Futcher A.B., Greider C.W., Harley C.B. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA 1992, 89:10114-10118.
2. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science 1998, 279:349-352.
3. Capper R., Britt-Compton B., Tankimanova M., Rowson J., Letsolo B., Man S., Haughton M., Baird D.M. The nature of telomere fusion and a definition of the critical telomere length in human cells. Genes Dev. 2007, 21:2495-2508.
4. Cascio S.M. Novel strategies for immortalization of human hepatocytes. Artif. Organs 2001, 25:529-538.
5. Cesare A.J., Reddel R.R. Alternative lengthening of telomeres: models, mechanisms and implications. Nat. Rev. Genet. 2010, 11:319-330.
6. Cifone M.A., Fidler I.J. Correlation of patterns of anchorage-independent growth with in vivo behavior of cells from a murine fibrosarcoma. Proc. Natl. Acad. Sci. USA 1980, 77:1039-1043.
7. Counter C.M., Avilion A.A., LeFeuvre C.E., Stewart N.G., Greider C.W., Harley C.B., Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 1992, 11:1921-1929.
8. de Lange T., Shiue L., Myers R.M., Cox D.R., Naylor S.L., Killery A.M., Varmus H.E. Structure and variability of human chromosome ends. Mol. Cell. Biol. 1990, 10:518-527.
9. Elenbaas B., Spirio L., Koerner F., Fleming M.D., Zimonjic D.B., Donaher J.L., Popescu N.C., Hahn W.C., Weinberg R.A. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 2001, 15:50-65.
10. Erdmann N., Harrington L.A. No attenuation of the ATM-dependent DNA damage response in murine telomerase-deficient cells. DNA Repair (Amst.) 2009, 8:347-353.
11. Fattah K.R., Ruis B.L., Hendrickson E.A. Mutations to Ku reveal differences in human somatic cell lines. DNA Repair (Amst.) 2008, 7:762-774.
12. *Power 3.1: tests for correlation and regression analyses. Behav. Res. Methods 2009, 41:1149-1160.
13. Flores I., Cayuela M.L., Blasco M.A. Effects of telomerase and telomere length on epidermal stem cell behavior. Science 2005, 309:1253-1256.
14. Grandin N., Charbonneau M. Telomerase- and Rad52-independent immortalization of budding yeast by an inherited-long-telomere pathway of telomeric repeat amplification. Mol. Cell. Biol. 2009, 29:965-985.
15. Greider C.W. Telomerase activation. One step on the road to cancer?. Trends Genet. 1999, 15:109-112.
16. Gritz L., Davies J. Plasmid-encoded hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae. Gene 1983, 25:179-188.
17. Gupta J., Han L.P., Wang P., Gallie B.L., Bacchetti S. Development of retinoblastoma in the absence of telomerase activity. J. Natl. Cancer Inst. 1996, 88:1152-1157.
18. Hahn W.C., Counter C.M., Lundberg A.S., Beijersbergen R.L., Brooks M.W., Weinberg R.A. Creation of human tumour cells with defined genetic elements. Nature 1999, 400:464-468.
19. Hahn W.C., Dessain S.K., Brooks M.W., King J.E., Elenbaas B., Sabatini D.M., DeCaprio J.A., Weinberg R.A. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol. Cell. Biol. 2002, 22:2111-2123.
20. Hahn W.C., Stewart S.A., Brooks M.W., York S.G., Eaton E., Kurachi A., Beijersbergen R.L., Knoll J.H., Meyerson M., Weinberg R.A. Inhibition of telomerase limits the growth of human cancer cells. Nat. Med. 1999, 5:1164-1170.
21. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
22. Harrington L., Zhou W., McPhail T., Oulton R., Yeung D.S.K., Mar V., Bass M.B., Robinson M.O. Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev. 1997, 11:3109-3115.
23. Hastie N.D., Dempster M., Dunlop M.G., Thompson A.M., Green D.K., Allshire R.C. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990, 346:866-868.
24. Hayflick L. Subculturing human diploid fibroblast cultures. Tissue Culture Methods and Applications, J 1973, 220-223. Academic Press, New York. P.F. Kruse, M.K. Patterson (Eds.).
25. Hemann M.T., Greider C.W. Wild-derived inbred mouse strains have short telomeres. Nucleic Acids Res. 2000, 28:4474-4478.
26. Hiyama E., Hiyama K., Yokoyama T., Matsuura Y., Piatyszek M.A., Shay J.W. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat. Med. 1995, 1:249-255.
27. Jaiswal K.R., Morales C.P., Feagins L.A., Gandia K.G., Zhang X., Zhang H.Y., Hormi-Carver K., Shen Y., Elder F., Ramirez R.D., et al. Characterization of telomerase-immortalized, non-neoplastic, human Barrett's cell line (BAR-T). Dis. Esophagus 2007, 20:256-264.
28. Lebel C., Rosonina E., Sealey D.C., Pryde F., Lydall D., Maringele L., Harrington L.A. Telomere maintenance and survival in saccharomyces cerevisiae in the absence of telomerase and RAD52. Genetics 2009, 182:671-684.
29. Li G., Nelsen C., Hendrickson E.A. Ku86 is essential in human somatic cells. Proc. Natl. Acad. Sci. USA 2002, 99:832-837.
30. Liang S., Kahlenberg M.S., Rousseau D.L., Hornsby P.J. Neoplastic conversion of human colon smooth muscle cells: No requirement for telomerase. Mol. Carcinog. 2008, 47:478-484.
31. Matsuo T., Shay J.W., Wright W.E., Hiyama E., Shimose S., Kubo T., Sugita T., Yasunaga Y., Ochi M. Telomere-maintenance mechanisms in soft-tissue malignant fibrous histiocytomas. J. Bone Joint Surg. Am. 2009, 91:928-937.
32. Mazurier F., Fontanellas A., Salesse S., Taine L., Landriau S., Moreau-Gaudry F., Reiffers J., Peault B., Di Santo J.P., de Verneuil H. A novel immunodeficient mouse model-RAG2 x common cytokine receptor gamma chain double mutants-requiring exogenous cytokine administration for human hematopoietic stem cell engraftment. J. Interferon Cytokine Res. 1999, 19:533-541.
33. Meznikova M., Erdmann N., Allsopp R., Harrington L.A. Telomerase reverse transcriptase-dependent telomere equilibration mitigates tissue dysfunction in mTert heterozygotes. Dis Model Mech 2009, 2:620-626.
34. Ouellette M.M., Liao M., Herbert B.-S., Johnson M., Holt S.E., Liss H.S., Shay J.W., Wright W.E. Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase. J. Biol. Chem. 2000, 275:10072-10076.
35. Parkinson E.K., Fitchett C., Cereser B. Dissecting the non-canonical functions of telomerase. Cytogenet. Genome Res. 2008, 122:273-280.
36. Sarin K.Y., Cheung P., Gilison D., Lee E., Tennen R.I., Wang E., Artandi M.K., Oro A.E., Artandi S.E. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 2005, 436:1048-1052.
37. Sealey D.C., Zheng L., Taboski M.A., Cruickshank J., Ikura M., Harrington L.A. The N-terminus of hTERT contains a DNA-binding domain and is required for telomerase activity and cellular immortalization. Nucleic Acids Res. 2010, 38:2019-2035.
38. Smogorzewska A., de Lange T. Different telomere damage signaling pathways in human and mouse cells. EMBO J. 2002, 21:4338-4348.
39. Steinert S., Shay J.W., Wright W.E. Transient expression of human telomerase extends the life span of normal human fibroblasts. Biochem. Biophys. Res. Commun. 2000, 273:1095-1098.
40. Stewart N., Bacchetti S. Expression of SV40 large T antigen, but not small t antigen, is required for the induction of chromosomal aberrations in transformed human cells. Virology 1991, 180:49-57.
41. Stewart S.A., Hahn W.C., O'Connor B.F., Banner E.N., Lundberg A.S., Modha P., Mizuno H., Brooks M.W., Fleming M., Zimonjic D.B., et al. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc. Natl. Acad. Sci. USA 2002, 99:12606-12611.
42. Strong M.A., Vidal-Cardenas S.L., Karim B., Yu H., Guo N., Greider C.W. Phenotypes in mTERT+/- and mTERT-/- mice are due to short telomeres, not telomere-independent functions of TERT. Mol. Cell. Biol. 2011, 31:2369-2379.
43. Sun B., Chen M., Hawks C.L., Hornsby P.J. Immortal ALT+ human cells do not require telomerase reverse transcriptase for malignant transformation. Cancer Res. 2005, 65:6512-6515.
44. Tabori U., Dome J.S. Telomere biology of pediatric cancer. Cancer Invest. 2007, 25:197-208.
45. Tatsumoto N., Hiyama E., Murakami Y., Imamura Y., Shay J.W., Matsuura Y., Yokoyama T. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer. Clin. Cancer Res. 2000, 6:2696-2701.
46. Ungrin M.D., Harrington L. Strict control of telomerase activation using Cre-mediated inversion. BMC Biotechnol. 2006, 6:10-14.
47. Vaziri H., Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 1998, 8:279-282.
48. Vidal-Cardenas S.L., Greider C.W. Comparing effects of mTR and mTERT deletion on gene expression and DNA damage response: a critical examination of telomere length maintenance-independent roles of telomerase. Nucleic Acids Res. 2010, 38:60-71.
49. Weinstein I.B., Joe A. Oncogene addiction. Cancer Res. 2008, 68:3077-3080. discussion 3080.
50. Wright W.E., Pereira-Smith O.M., Shay J.W. Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol. Cell. Biol. 1989, 9:3088-3092.
51. Wyatt H.D., Tsang A.R., Lobb D.A., Beattie T.L. Human telomerase reverse transcriptase (hTERT) Q169 is essential for telomerase function in vitro and in vivo. PLoS ONE 2009, 4:e7176.
52. Xu L., Blackburn E.H. Human cancer cells harbor T-stumps, a distinct class of extremely short telomeres. Mol. Cell 2007, 28:315-327.
53. Zhang X., Mar V., Zhou W., Harrington L., Robinson M.O. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev. 1999, 13:2388-2399.